Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 4/2019

01-06-2019 | Ultrasound | Original Article

Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate

Authors: Emmanuelle Trébouet, Sahar Bannani, Matthieu Wargny, Christophe Leux, Cécile Caillard, Françoise Kraeber-Bodéré, Karine Renaudin, Lucy Chaillous, Éric Mirallié, Catherine Ansquer

Published in: Langenbeck's Archives of Surgery | Issue 4/2019

Login to get access

Abstract

Background

Mild primary hyperparathyroidism (serum calcium ≤ 2.85 mmol/L) is the most representative form of pHPT nowadays. The aim of this study was to evaluate its subtypes and the multiglandular disease (MGD) rate as it may lower the sensitivity of preoperative parathyroid scintigraphy and the surgical cure rate.

Methods

We retrospectively included patients with mild pHPT who underwent parathyroid dual-tracer scintigraphy with 99mTc-MIBI SPECT/CT and surgery between January 2013 and December 2015. Cure was defined as normalization of serum calcium (or PTH in the normocalcemic form) at 6 months. MGD was defined by either two abnormal resected glands or persistent disease after resection of at least one abnormal gland.

Results

We included 121 patients. Median preoperative serum calcium was 2.68 mmol/L and median PTH was 83.4 pg/mL. A total of 141 glands were resected (95 adenomas, 33 hyperplasias). The subtypes were 57% classic, 32.2% normohormonal, and 10.7% normocalcemic. MGD occurred in 23.5% of patients divided as 13%, 30%, and 64% respectively (p = 0.0011). The surgical cure rate was 85.2%.
The normocalcemic form had lower cure rate than the normohormonal (45% vs 84%, p = 0.018) and classic forms (45% vs 93%, p = 0.0006). MIBI scintigraphy identified at least one abnormal lesion, later confirmed by the pathologist in 90/98 patients, making the sensitivity per patient 91.8% (95% CI 84.1–96.2%).

Conclusions

MGD is strongly associated with mild pHPT, especially the normocalcemic form where it accounts for 64% of cases. Bilateral neck exploration should be performed in this population to improve the cure rate, even if the scintigraphy shows a single focus.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 94:335–339CrossRefPubMedPubMedCentral Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 94:335–339CrossRefPubMedPubMedCentral
2.
go back to reference Barczyński M, Bränström R, Dionigi G, Mihai R (2015) Sporadic multiple parathyroid gland disease—a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck's Arch Surg 400:887–905CrossRef Barczyński M, Bränström R, Dionigi G, Mihai R (2015) Sporadic multiple parathyroid gland disease—a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck's Arch Surg 400:887–905CrossRef
3.
go back to reference Low RA, Katz AD (1998) Parathyroidectomy via bilateral cervical exploration: a retrospective review of 866 cases. Head Neck 20:583–587CrossRefPubMed Low RA, Katz AD (1998) Parathyroidectomy via bilateral cervical exploration: a retrospective review of 866 cases. Head Neck 20:583–587CrossRefPubMed
4.
go back to reference Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561–3569CrossRefPubMedPubMedCentral Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561–3569CrossRefPubMedPubMedCentral
5.
go back to reference Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99:3580–3594CrossRefPubMedPubMedCentral Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99:3580–3594CrossRefPubMedPubMedCentral
6.
go back to reference Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallié E (2007) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141:153–159; discussion 159-160 CrossRefPubMed Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallié E (2007) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141:153–159; discussion 159-160 CrossRefPubMed
7.
go back to reference Blanchard C, Mathonnet M, Sebag F, Caillard C, Kubis C, Drui D, van Nuvel E, Ansquer C, Henry JF, Masson D, Kraeber-Bodéré F, Hardouin JB, Zarnegar R, Hamy A, Mirallié E (2014) Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study. Ann Surg Oncol 21:3534–3540CrossRefPubMed Blanchard C, Mathonnet M, Sebag F, Caillard C, Kubis C, Drui D, van Nuvel E, Ansquer C, Henry JF, Masson D, Kraeber-Bodéré F, Hardouin JB, Zarnegar R, Hamy A, Mirallié E (2014) Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study. Ann Surg Oncol 21:3534–3540CrossRefPubMed
8.
go back to reference Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M, Cariou B, Archambeaud F, Rodien P, Henry JF, Zarnegar R, Hardouin JB, Mirallié E (2013) Surgery for ‘asymptomatic’ mild primary hyperparathyroidism improves some clinical symptoms postoperatively. Eur J Endocrinol 169:665–672CrossRefPubMed Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M, Cariou B, Archambeaud F, Rodien P, Henry JF, Zarnegar R, Hardouin JB, Mirallié E (2013) Surgery for ‘asymptomatic’ mild primary hyperparathyroidism improves some clinical symptoms postoperatively. Eur J Endocrinol 169:665–672CrossRefPubMed
9.
go back to reference Lim JY, Herman MC, Bubis L, Epelboym I, Allendorf JD, Chabot JA, Lee JA, Kuo JH (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRefPubMed Lim JY, Herman MC, Bubis L, Epelboym I, Allendorf JD, Chabot JA, Lee JA, Kuo JH (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRefPubMed
10.
go back to reference Paek SH, Kim S-J, Choi JY, Lee KE (2018) Clinical usefulness of intraoperative parathyroid hormone monitoring for primary hyperparathyroidism. Ann Surg Treat Res 94:69–73CrossRefPubMedPubMedCentral Paek SH, Kim S-J, Choi JY, Lee KE (2018) Clinical usefulness of intraoperative parathyroid hormone monitoring for primary hyperparathyroidism. Ann Surg Treat Res 94:69–73CrossRefPubMedPubMedCentral
11.
go back to reference Cayo AK, Sippel RS, Schaefer S, Chen H (2009) Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease. Ann Surg Oncol 16:3450–3454CrossRefPubMed Cayo AK, Sippel RS, Schaefer S, Chen H (2009) Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease. Ann Surg Oncol 16:3450–3454CrossRefPubMed
13.
go back to reference Wong KK, Fig LM, Gross MD, Dwamena BA (2015) Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 36:363–375CrossRefPubMed Wong KK, Fig LM, Gross MD, Dwamena BA (2015) Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 36:363–375CrossRefPubMed
14.
go back to reference Ansquer C, Mirallié E, Carlier T et al (2008) Preoperative localization of parathyroid lesions. Value of 99mTc-MIBI tomography and factors influencing detection. Nukl Nucl Med 47:158–162CrossRef Ansquer C, Mirallié E, Carlier T et al (2008) Preoperative localization of parathyroid lesions. Value of 99mTc-MIBI tomography and factors influencing detection. Nukl Nucl Med 47:158–162CrossRef
15.
go back to reference Medas F, Erdas E, Longheu A, Gordini L, Pisano G, Nicolosi A, Calò PG (2016) Retrospective evaluation of the pre- and postoperative factors influencing the sensitivity of localization studies in primary hyperparathyroidism. Int J Surg Lond Engl 25:82–87CrossRef Medas F, Erdas E, Longheu A, Gordini L, Pisano G, Nicolosi A, Calò PG (2016) Retrospective evaluation of the pre- and postoperative factors influencing the sensitivity of localization studies in primary hyperparathyroidism. Int J Surg Lond Engl 25:82–87CrossRef
16.
go back to reference Swanson TW, Chan SK, Jones SJ, Bugis S, Irvine R, Belzberg A, Levine D, Wiseman SM (2010) Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg 199:614–620CrossRefPubMed Swanson TW, Chan SK, Jones SJ, Bugis S, Irvine R, Belzberg A, Levine D, Wiseman SM (2010) Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg 199:614–620CrossRefPubMed
17.
go back to reference Carlier T, Oudoux A, Mirallié E, Seret A, Daumy I, Leux C, Bodet-Milin C, Kraeber-Bodéré F, Ansquer C (2008) 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging 35:637–643CrossRefPubMed Carlier T, Oudoux A, Mirallié E, Seret A, Daumy I, Leux C, Bodet-Milin C, Kraeber-Bodéré F, Ansquer C (2008) 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging 35:637–643CrossRefPubMed
19.
go back to reference Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom Off J Int Soc Clin Densitom 14:79–84CrossRef Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom Off J Int Soc Clin Densitom 14:79–84CrossRef
20.
go back to reference Michaud L, Burgess A, Huchet V, Lefèvre M, Tassart M, Ohnona J, Kerrou K, Balogova S, Talbot JN, Périé S (2014) Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99:4531–4536CrossRefPubMed Michaud L, Burgess A, Huchet V, Lefèvre M, Tassart M, Ohnona J, Kerrou K, Balogova S, Talbot JN, Périé S (2014) Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99:4531–4536CrossRefPubMed
21.
go back to reference Kluijfhout WP, Vorselaars WMCM, van den Berk SAM, Vriens MR, Borel Rinkes IHM, Valk GD, van Dalen T, de Klerk JMH, de Keizer B (2016) Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun 37:1246–1252CrossRefPubMed Kluijfhout WP, Vorselaars WMCM, van den Berk SAM, Vriens MR, Borel Rinkes IHM, Valk GD, van Dalen T, de Klerk JMH, de Keizer B (2016) Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun 37:1246–1252CrossRefPubMed
Metadata
Title
Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate
Authors
Emmanuelle Trébouet
Sahar Bannani
Matthieu Wargny
Christophe Leux
Cécile Caillard
Françoise Kraeber-Bodéré
Karine Renaudin
Lucy Chaillous
Éric Mirallié
Catherine Ansquer
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 4/2019
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-019-01782-1

Other articles of this Issue 4/2019

Langenbeck's Archives of Surgery 4/2019 Go to the issue